TotalMarketCap

Burning Rock Biotech

BNRNasdaq ChinaHealth CareMedical Specialities

Market cap

$139.212 M

$13.20 +2.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Burning Rock Biotech (BNR) has a market capitalization of $139.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$77.2M

#2575 by revenue

Earnings

-$7.92M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #34BiodesixBDSX$211.0M
  2. #35ExagenXGN$181.4M
  3. #36Burning Rock BiotechBNR$139.2M
  4. #37Kewaunee ScientificKEQU$98.0M
  5. #38Sera PrognosticsSERA$82.5M

What if Burning Rock Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,677,409

Per share 202,834× higher

Bitcoin $1.53T

$144,869.94

Per share 10,975× higher

Apple $5.02T

$475,594.49

Per share 36,030× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Burning Rock Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.